No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency

Neuromuscul Disord. 2020 Apr;30(4):340-345. doi: 10.1016/j.nmd.2020.02.008. Epub 2020 Feb 24.

Abstract

This case report investigated exercise metabolism and the effect of oral sucrose and intravenous glucose supplementation in a 30-year-old, mildly affected man with muscle phosphorylase b kinase (PHK) deficiency caused by a novel c.586G>A mutation in the PHKA1 gene. Only 12 patients with PHK deficiency have been reported and it is unclear to what extent patients exhibit symptoms during exercise. Carbohydrate and fat metabolism were measured during 30 min of exercise at ∼ 70% of peak oxidative capacity using stabile isotope technique and signaling proteins and enzymes in the energy pathway were analyzed by Western blot. Results were compared to four healthy subjects. These studies show that neither oral nor intravenous glucose improved exercise tolerance in this patient with PHK deficiency. Despite Western blots indicated affected metabolism on protein level, systemic substrate turnover studies showed that carbohydrate and fatty acid oxidations were normal.

Keywords: Carbohydrate and fat metabolism; Glycogen storage disease; Muscle Glycogenosis; Muscle phosphorylase kinase deficiency.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Administration, Oral
  • Adult
  • Exercise Tolerance / drug effects*
  • Glucose / administration & dosage
  • Glucose / pharmacology*
  • Glycogen Storage Disease* / genetics
  • Glycogen Storage Disease* / metabolism
  • Glycogen Storage Disease* / physiopathology
  • Humans
  • Male
  • Sucrose / administration & dosage
  • Sucrose / pharmacology*

Substances

  • Sucrose
  • Glucose

Supplementary concepts

  • Glycogen Storage Disease Type Ix